Related Experiment Video
Updated: Nov 13, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Serotonin and dopamine receptors profile on peripheral immune cells from patients with temporal lobe epilepsy
Érica Leandro Marciano Vieira1, Maria Carolina Machado da Silva2, Ana Paula Gonçalves3
1Centre for Addiction and Mental Health - CAMH, Toronto M5T 1R8, Canada.
Insights
Immune cells in epilepsy patients show altered serotonin and dopamine receptor expression. These changes in temporal lobe epilepsy with hippocampal sclerosis may impact disease understanding.
Area of Science:
- Neuroimmunology
- Epilepsy Pathophysiology
- Cellular Immunology
Background:
- Inflammation and immune cells play a role in neurological diseases like epilepsy.
- Leukocytes and inflammatory mediators can lower seizure threshold and alter neural pathways.
- Understanding immune cell phenotypes is crucial for epilepsy research.
Purpose of the Study:
- To investigate alterations in serotonin and dopamine receptor expression on circulating immune cells in patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS).
- To explore potential links between these receptor changes and TLE-HS pathophysiology.
Main Methods:
- Collected blood samples from 17 TLE-HS patients and 21 controls.
- Isolated peripheral blood mononuclear cells (PBMCs) and performed ex vivo staining.
- Utilized flow cytometry to evaluate serotonin (5-HT) and dopamine (D) receptor expression on lymphocytes, monocytes, and granulocytes.
Main Results:
- Patients with TLE-HS exhibited higher expression of 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT4 receptors on innate immune cells and lymphocytes compared to controls.
- Dopamine receptor expression (D1, D2, D4, D5) was elevated on innate immune cells in TLE-HS patients.
- Increased D2 receptor expression was observed on lymphocytes from TLE-HS patients.
Conclusions:
- Significant alterations in serotonin and dopamine receptor expression exist on immune blood cells in TLE-HS patients.
- These findings suggest a potential role for altered neurochemical signaling in immune cells within TLE-HS.
- Further research is needed to elucidate the biological significance of these receptor expression changes in epilepsy.
Abstract:
The role of inflammation and immune cells has been demonstrated in neurological diseases, including epilepsy. Leukocytes, as well as inflammatory mediators, contribute to abnormal processes that lead to a reduction in seizure threshold and synaptic reorganization. In this sense, identifying different phenotypes of circulating immune cells is essential to understanding the role of these cells in epilepsy. Immune cells can express a variety of surface markers, including neurotransmitter receptors, such as serotonin and dopamine. Alteration in these receptors expression patterns may affect the level of inflammatory mediators and the pathophysiology of epilepsy. Therefore, in the current study, we evaluated the expression of dopamine and serotonin receptors on white blood cells from patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS). Blood samples from 17 patients with TLE-HS and 21 controls were collected. PBMC were isolated and stained ex vivo for flow cytometry. We evaluated the expression of serotonin (5-HT1A, 5-HT1B, 5-HT2, 5-HT2B, 5-HT2C, 5-HT3, 5-HT4), and dopamine receptors (D1, D2, D3, D4, and D5) on the cell surface of lymphocytes and innate immune cells (monocytes and granulocytes). Our results demonstrated that innate cells and lymphocytes from patients with TLE-HS showed high mean fluorescent intensity (MFI) for 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT4 compared to controls. No difference was observed for 5-HT2B. For dopamine receptors, the expression of D1, D2, D4, and D5 receptors was higher on innate cells from patients with TLE-HS when compared to controls for the MFI. Regarding lymphocytes population, D2 expression was increased in patients with TLE-HS. In conclusion, there are alterations in the expression of serotonin and dopamine receptors on immune blood cells of patients with TLE-HS. Although the biological significance of these findings still needs to be further investigated, these changes may contribute to the understanding of TLE-HS pathophysiology.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

